Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Innovations in Microfluidics 2020

Balaji Panchapakesan's Biography



Balaji Panchapakesan, Professor, Department of Mechanical Engineering, Worcester Polytechnic Institute (WPI)

Dr. Balaji Panchapakesan is a Professor of Mechanical Engineering at Worcester Polytechnic Institute in Worcester, MA. He invented the Nanotube-CTC-Chip microarray technology. He has published over 100 articles in leading journals, and conferences. He is a conference chair of the SPIE Nanoscience and Engineering conference. His interests are in enabling nanoscience for wide variety of applications including capture of circulating biomarkers.

Balaji Panchapakesan Image

Liquid Biopsy using Nanotube-CTC-Chip

Tuesday, 18 August 2020 at 14:30

Add to Calendar ▼2020-08-18 14:30:002020-08-18 15:30:00Europe/LondonLiquid Biopsy using Nanotube-CTC-ChipInnovations in Microfluidics 2020 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com

We report the further development of the nanotube-CTC-chip for isolation of tumor-derived epithelial cells (circulating tumor cells, CTCs) from peripheral blood, with high purity, by exploiting the physical mechanisms of preferential adherence of CTCs on a nanotube surface. The nanotube-CTC-chip is a new 76-element microarray technology that combines carbon nanotube surfaces with microarray batch manufacturing techniques for the capture and isolation of tumor-derived epithelial cells. Using a combination of red blood cell (RBC) lysis and preferential adherence, we demonstrate the capture and enrichment of CTCs with a 5-log reduction of contaminating WBCs. The nanotube-CTC-chip successfully captured CTCs in the peripheral blood of breast cancer patients (stage 1–4) with a range of 4–238 CTCs per 8.5 ml blood or 0.5–28 CTCs per ml. CTCs (based on CK8/18, Her2, EGFR) were successfully identified in breast cancer patients, and no CTCs were captured in healthy controls. CTC enumeration based on multiple markers using the nanotube-CTC-chip enables dynamic views of metastatic progression and could potentially have predictive capabilities for diagnosis and treatment response.


Add to Calendar ▼2020-08-17 00:00:002020-08-18 00:00:00Europe/LondonInnovations in Microfluidics 2020Innovations in Microfluidics 2020 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com